This study aims to explore the effect of CGA on NAFLD induced by high-fat diet (HFD) and whether it regulates the gut microbiota and Glucagon-like peptide-1 (GLP-1). The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.